254. Porphyria Clinical trials / Disease details

Clinical trials : 72 / Drugs : 53 - (DrugBank : 16) / Drug target genes : 19 - Drug target pathways : 35

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02922413 (ClinicalTrials.gov)	October 30, 2015	1/1/2016	Panhematin for Prevention of Acute Attacks of Porphyria	Safety and Efficacy of Panhematin™ for Prevention of Acute Attacks of Porphyria	Acute Intermittent Porphyria;Hereditary Coproporphyria;Variegate Porphyria	Biological: Hemin for injection;Other: Placebo	The University of Texas Medical Branch, Galveston	NULL	Recruiting	18 Years	N/A	All	20	Phase 2	United States
2	NCT02935400 (ClinicalTrials.gov)	April 28, 2014	13/10/2016	Acute Porphyria Biomarkers for Disease Activity	Acute Porphyrias: Biomarkers for Disease Activity and Response to Treatment	Acute Intermittent Porphyria;Hereditary Coproporphyria;Variegate Porphyria	Drug: Hemin	The University of Texas Medical Branch, Galveston	NULL	Active, not recruiting	18 Years	N/A	All	50		United States

First Previous1Next Last